| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 05/03/2001 | WO2001031038A1 Genetic engineering immobilization of heteromer peptides |
| 05/03/2001 | WO2000056774A8 Methods of using bioelastomers |
| 05/02/2001 | EP1095058A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 05/02/2001 | CN1293205A Target-specific cytotoxin chimeric with short-peptide harmone |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 04/26/2001 | WO2001028575A1 Proteoglycan, a bioactive substance from plants |
| 04/25/2001 | EP1093458A1 Process for the preparation of resin-bound cyclic peptides |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/12/2001 | WO2001025287A1 Affinity macroligands |
| 04/11/2001 | EP1090928A1 Polymers loaded with bioactive agents |
| 04/11/2001 | CN1291200A Device for producing polymer support material in form of porous polymer beand |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/05/2001 | WO2001023413A1 Extracorporeal endotoxin removal method |
| 04/05/2001 | DE19945398A1 Elektrochemische Detektion von sequenzspezifischen Nukleinsäure-Oligomer-Hybridisierungsereignissen Electrochemical detection of sequence-specific nucleic acid oligomer hybridization events |
| 04/05/2001 | DE10046508A1 Magnetic nanoparticles carrying specific binding agent reactive with intracellular molecule, useful for separating cells, particularly cancerous, and biomolecules |
| 04/04/2001 | EP0788515B1 Non-antigenic branched polymer conjugates |
| 04/03/2001 | US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins |
| 03/30/2001 | CA2321321A1 Polymers loaded with bioactive agents |
| 03/29/2001 | WO2001021660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 03/29/2001 | WO2001021635A2 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events |
| 03/29/2001 | WO2000058005A3 Immunoadsorber for use in sepsis therapy |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/28/2001 | EP0779815B1 Surface-modifying copolymers having cell adhesion properties |
| 03/22/2001 | WO2001019405A2 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 03/22/2001 | CA2384429A1 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 03/20/2001 | US6203814 Surface treatment of fullerene carbon; oxidation |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018060A1 Materials for extracorporeal circulation, adsorbents for diabetic complication factors, containers for eliminating diabetic complication factors and method of eliminating diabetic complication factors |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082104A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 03/08/2001 | WO2001016352A1 Methods for encoding and sorting in vitro translated proteins |
| 03/08/2001 | WO2001016328A2 Method for the production of regular nanostructures |
| 03/08/2001 | WO2001015736A2 Interferon-beta conjugates |
| 03/08/2001 | CA2382545A1 Methods for encoding and sorting in vitro translated proteins |
| 03/08/2001 | CA2380760A1 New interferon beta-like molecules |
| 03/07/2001 | EP1080368A1 Molecular rod and uses |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/06/2001 | US6197506 Using substrate having over 100 different polynucleotides at density of over 50 different polynucleotides per square centimeter to generate hybridization patterns and distinguish between two nucleic acid samples; heredity; diagnosis |
| 03/01/2001 | WO2001014425A1 Multipurpose diagnostic systems using protein chips |
| 03/01/2001 | WO2001013937A1 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 03/01/2001 | DE19941448A1 Verfahren zur Herstellung von regelmäßigen Nanostrukturen A process for producing regular nanostructures |
| 03/01/2001 | CA2383562A1 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 02/28/2001 | CN1285917A Method comprising capture molecule fixed on disc surface |
| 02/27/2001 | US6194552 Masking antitope of antibody with orientation directing agent to form complex, then immobilizing complex on support so that antitope is oriented away from support; improved binding efficiency |
| 02/27/2001 | US6194386 Labelled peptide compounds |
| 02/27/2001 | US6194385 Calcium-binding protein |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/22/2001 | WO2001012232A2 Process to make a sustained release formulation |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/13/2001 | CA2067224C Hirudin/polyalkylene glycol conjugates |
| 02/13/2001 | CA2028156C Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides |
| 02/07/2001 | EP1073901A2 Immobilized substrate, separation gels produced therewith and method for detecting enzymatic activity after electrophoretic protein separation |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP0862624A4 Water soluble cross-linking agents |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/01/2001 | WO2001007657A1 Peptide acceptor ligation methods |
| 02/01/2001 | WO2001007581A1 Method for encapsulating macromolecules and/or particles and use thereof |
| 02/01/2001 | WO2001007477A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2693274A1 Peptide acceptor ligation methods |
| 02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 01/31/2001 | EP1071442A1 Methods and compositions for peptide synthesis |
| 01/31/2001 | CN1282339A Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 01/30/2001 | US6180378 Immobilization of bioactive protein in phyllosilicates |
| 01/24/2001 | EP1070256A1 Method for fixing a biological molecule on a support surface |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | CN1280986A Process for synthesizing chiral fixed phase of liquid-phase chromatographic protein |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177085 Immunology |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/17/2001 | EP1068356A1 Addressable protein arrays |
| 01/17/2001 | EP1068228A1 Protease conjugates |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/10/2001 | EP1066028A2 Methods and devices for modulating the immune response |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES |
| 01/02/2001 | US6169072 Cyclic adhesion inhibitors |
| 01/02/2001 | US6168913 Coding combinatorial libraries with fluorine tags |
| 12/28/2000 | CA2778826A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 12/20/2000 | EP0762875B1 Microparticle delivery system |
| 12/14/2000 | WO2000074722A2 Modification of biological elements |
| 12/14/2000 | WO2000050570A3 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells |
| 12/12/2000 | US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses |
| 12/07/2000 | WO2000073341A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 12/07/2000 | WO2000073337A1 Polymer conjugates of hedgehog proteins and uses |
| 12/07/2000 | WO2000072869A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 12/07/2000 | CA2375700A1 Polymer conjugates of hedgehog proteins and uses |
| 12/07/2000 | CA2373047A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 12/06/2000 | EP1056882A1 One dimensional chemical compound arrays and methods for assaying them |
| 12/06/2000 | EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 12/05/2000 | CA2026655C Process for the solubilisation of peptides and process for the synthesis of peptides |